Polycystic kidney disease

C Bergmann, LM Guay-Woodford, PC Harris… - Nature reviews Disease …, 2018 - nature.com
Cystic kidneys are common causes of end-stage renal disease, both in children and in
adults. Autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive …

Autosomal dominant polycystic kidney disease

E Cornec-Le Gall, A Alam, RD Perrone - The Lancet, 2019 - thelancet.com
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary
kidney disease and one of the most common causes of end-stage kidney disease. Multiple …

[HTML][HTML] Ciliopathies and the kidney: a review

DJ McConnachie, JL Stow, AJ Mallett - American Journal of Kidney …, 2021 - Elsevier
Primary cilia are specialized sensory organelles that protrude from the apical surface of most
cell types. Over the past two decades, they have been found to play important roles in tissue …

An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney …

RU Müller, AL Messchendorp, H Birn… - Nephrology Dialysis …, 2022 - academic.oup.com
Approval of the vasopressin V2 receptor antagonist tolvaptan—based on the landmark
TEMPO 3: 4 trial—marked a transformation in the management of autosomal dominant …

Autosomal dominant polycystic kidney disease

PA Gabow - New England Journal of Medicine, 1993 - Mass Medical Soc
Autosomal dominant polycystic kidney disease is one of the most common hereditary
disorders, being 10 times more common than sickle cell disease, 15 times more common …

Assessing risk of rapid progression in autosomal dominant polycystic kidney disease and special considerations for disease-modifying therapy

FT Chebib, VE Torres - American Journal of Kidney Diseases, 2021 - Elsevier
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited
cause of kidney failure, accounting for 5%-10% of cases. Predicting which patients with …

Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD)

RD Perrone, KZ Abebe, TJ Watnick, AD Althouse… - Kidney international, 2021 - Elsevier
Autosomal dominant polycystic kidney disease (ADPKD) is characterized by growth of
kidney cysts and glomerular filtration rate (GFR) decline. Metformin was found to impact …

Aquaporin 2 regulation: implications for water balance and polycystic kidney diseases

ETB Olesen, RA Fenton - Nature Reviews Nephrology, 2021 - nature.com
Targeting the collecting duct water channel aquaporin 2 (AQP2) to the plasma membrane is
essential for the maintenance of mammalian water homeostasis. The vasopressin V2 …

Oral delivery of metformin by chitosan nanoparticles for polycystic kidney disease

J Wang, D Chin, C Poon, V Mancino, J Pham… - Journal of Controlled …, 2021 - Elsevier
Nanoparticle drug delivery has many advantages over small molecule therapeutics,
including reducing off-target side effects and increasing drug potency. However, many …

Activation of NRF2 ameliorates oxidative stress and cystogenesis in autosomal dominant polycystic kidney disease

Y Lu, Y Sun, Z Liu, Y Lu, X Zhu, B Lan, Z Mi… - Science Translational …, 2020 - science.org
Oxidative stress is emerging as a crucial contributor to the pathogenesis of autosomal
dominant polycystic kidney disease (ADPKD), but the molecular mechanisms underlying the …